{"benefits":{"title":"Evidence Highlights","features":[{"icon":"smile-plus","title":"Pain reduction vs placebo","description":"Phase IIb RCTs show significant VAS and WOMAC pain improvements at 6–12 months."},{"title":"Functional gains","icon":"trending-up","description":"Trials report better WOMAC function and KOOS scores compared with hyaluronic acid."},{"icon":"shield-check","title":"Favourable safety","description":"Reported adverse events are typically mild (transient soreness or swelling)."}]},"howItWorks":{"subtitle":"SVF and cultured ADMSCs provide cushioning cells plus anti-inflammatory signalling.","title":"Why Fat-Derived Cells Help Joints","background":"default","variant":"default","content":"Autologous adipose tissue is rich in mesenchymal stem cells, pericytes, and cytokines. When injected under ultrasound guidance, these cells can dampen inflammation, support cartilage matrix production, and improve shock absorption within the joint.","enabled":true,"benefits":[{"icon":"circle-dollar-sign","title":"Biologic cushioning","description":"Adipose cells add volume and synovial support to reduce mechanical stress."},{"description":"Paracrine factors modulate cytokines linked to OA pain and swelling.","icon":"activity","title":"Anti-inflammatory signalling"},{"title":"Matrix support","icon":"grid","description":"MSCs can aid cartilage matrix turnover and may slow radiographic progression."}]},"alternativeTitles":["SVF Knee OA Evidence","Adipose MSC Clinical Data"],"longDescription":"Multiple peer-reviewed trials have evaluated adipose-derived mesenchymal stem cells (ADMSCs) and stromal vascular fraction (SVF) for degenerative knee disease. Studies range from proof-of-concept Phase IIb RCTs to phase III double-blind trials, consistently reporting reductions in pain scores and improved WOMAC function versus placebo or hyaluronic acid at 6–12 months.","categoryId":"scientific-evidence","tagline":"Adipose-derived stem cell injections for osteoarthritis with RCT support","subcategoryId":"treatments","shortTitle":"Fat-Derived Stem Cells","id":"fat-derived-stem-cell-joint-therapy","faq":[{"question":"What outcomes did RCTs measure?","answer":"Most randomized trials used WOMAC and VAS pain as primary endpoints, with follow-up between 6 and 12 months."},{"answer":"Phase III data suggest benefits can persist beyond one year, with some cohorts reporting relief up to two years.","question":"How durable are results?"},{"answer":"Studies report low complication rates—mainly temporary post-injection soreness—when using autologous adipose cells.","question":"Are there safety concerns?"}],"whatToExpect":{"steps":[{"icon":"scan","title":"Baseline & Imaging","description":"OA severity documented with radiographs or MRI; pain/function scored (WOMAC, VAS)."},{"description":"Ultrasound-guided intra-articular SVF or cultured MSC injection.","icon":"syringe","title":"Single Injection"},{"icon":"calendar-clock","title":"Follow-up 3–12 Months","description":"Pain and function reassessed; several trials show sustained improvements to 1–2 years."}],"variant":"timeline","title":"What Studies Typically Report","enabled":true},"hero":{"badge":"Clinical Research","subheadline":"Phase IIb–III data show meaningful pain and function gains in knee osteoarthritis.","headline":"Evidence for Adipose-Derived Stem Cell Therapy","image":"https://images.unsplash.com/photo-1505751172876-fa1923c5c528?w=1920&q=80"},"quickStats":{"sessions":"Single injection (+ boosters if needed)","anesthesia":"Local + light sedation","resultsLast":"12-24 months","resultsVisible":"6-12 weeks","downtime":"48-72 hrs","painLevel":"Low","duration":"Day procedure"},"overview":{"highlights":["Phase IIb and III RCTs against placebo and hyaluronic acid","Measured endpoints: WOMAC, VAS pain, and MRI cartilage grading","Follow-up windows from 6 months to 2+ years"],"content":"Prospective studies report sustained pain reduction and functional improvement after intra-articular ADMSC or SVF injections. Randomized controlled trials versus placebo or hyaluronic acid demonstrate superior WOMAC and VAS scores at 6–12 months, with some MRI evidence of cartilage quality improvements.","title":"What the Literature Shows","image":"https://images.unsplash.com/photo-1582719478250-c89cae4dc85b?w=1400&q=80"},"cta":{"secondaryButton":"Call the clinic","primaryButton":"Book a consultation","title":"Ready to Discuss SVF or ADMSC Therapy?","subtitle":"Bring your imaging and goals—we will match them to the evidence."},"title":"Scientific Evidence for Fat Derived Stem Cell Joint Therapy","whyChooseDrSNA":{"enabled":true,"subtitle":"Consultant-led protocols that mirror published methodology.","title":"Why Our Approach","features":[{"title":"Ultrasound guidance","icon":"crosshair","description":"Precise intra-articular placement mirrors trial protocols to optimise outcomes."},{"description":"Consistent SVF preparation to match doses used in published studies.","title":"Standardised processing","icon":"settings"},{"icon":"heart-pulse","title":"Rehab integration","description":"Physiotherapy is aligned to the biological recovery window reported in trials."}]},"description":"A review of prospective and randomized studies using stromal vascular fraction and cultured adipose-derived MSCs for knee osteoarthritis.","seo":{"canonicalUrl":"/treatments/scientific-evidence/treatments/fat-derived-stem-cell-joint-therapy","metaDescription":"Explore the clinical trials behind adipose-derived stem cell injections for knee osteoarthritis, including randomized and placebo-controlled studies.","h1":"Fat-Derived Stem Cell Therapy: Clinical Evidence","keywords":["adipose stem cell knee study","stromal vascular fraction evidence","fat derived stem cell osteoarthritis"],"metaTitle":"Scientific Evidence | Fat-Derived Stem Cell Joint Therapy"}}